LYNCH BIOLOGICS, LLC

ABSOLVE

Pharmaceutical preparations for wounds; Wound dressings; Prescription drug, namely, a wound healing growth factor;

GEM

Growth factor enhanced pharmaceutical preparations for the treatment of 1. bone and soft tissue defects in a wide range of indications such as periodontal, cranio-maxillofacial (head, jaw, and face), osteoporotic, sports medicine, other orthopedic applications, and 2. related wound healing and tissue repair;

GEM 21S

Growth factor enhanced pharmaceutical preparations for the treatment of periodontal and cranio-maxillofacial (CMF) bone and soft tissue defects, namely bone and tissue defects of the head, jaw, and face and related wound healing and tissue repair;

GEM-22A

Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Human allograft tissue;GEM-TWENTY TWO A;

GEM-22X

Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Xenograft tissue;

GEM-AMATRIX

Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Wound dressings; Human allograft tissue;

GEM-RCM

Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Wound dressings;

GEM-SMATRIX

Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Wound dressings;

GEM-XMATRIX

Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Wound dressings;